Covert manifestations of child abuse.

A. Grace,M. Kalinkiewicz,A. Drake-lee

DOI: https://doi.org/10.1136/bmj.289.6451.1041-a

1984-10-20

British Medical Journal

Abstract:3 observations de lesions du tympan et de l'oreille, avec en plus dans un cas lesions de la bouche et du palais et dans un autre perforation mastoidienne, brulure d'une main et introduction d'epingles, toutes lesions provoquees par des meres desequilibrees

What problem does this paper attempt to address?

Efficacy of Ctla4-Ig in Preventing Acute Rejection of Fully Allogeneic Heart Allografts in Sensitized Recipients

J. Chen,J. Young,V. Vu,D. Ying,Q. Wang,A. Chong

DOI: https://doi.org/10.1097/00007890-201407151-01039

2014-01-01

Transplantation

Abstract:Belatacept, a high-affinity variant of CTLA4-Ig, is a recently approved immunosuppressive agent for the prevention of acute rejection. It functions as a potent antagonist of the CD28-B7 interactions, thereby inhibiting T cell co-stimulation and activation. Experimental data involving the transient use of CTLA4-Ig to induce allograft tolerance have shaped the current paradigm that CTLA-4Ig is ineffective at inhibiting memory T cell responses, and by extension T-dependent alloantibody responses. This resistance is explained by the acquisition of additional activation-induced costimulatory molecules by memory T cells. We noted that the efficacy of CTLA4-Ig as a continuously administered drug for controlling rejection in sensitized recipients has not been investigated. Here we report on the efficacy of CTLA4-Ig in preventing acute rejection in sensitized C57BL/6 recipients that had received BALB/c spleen cell transfusion 3-6 months previously. We set up four experimental groups. Group 1 (N=5): sensitized mice with HTX and CTLA4-Ig treated (Day -2, Day 0, Day2, then weekly (1 mg/dose) Group 2 (N=3): sensitized mice with HTX and no CTLA4-Ig, Group 3: (N=10) naive mice with HTX and CTLA4-Ig treated, Group 4 (N=10): naive mice with HTX and no CTLA4-Ig. In the untreated Groups 2 & 4, allografts were rejected within 7 days post-transplantation, whereas in Group 3 of naive mice receiving CTLA4-Ig, all the grafts survived long-term (>90 days). In Group 1 of sensitized recipients receiving CTLA4-Ig, the allografts survived for 42, 42, 49, >90, >90 days. The pre-transplant donor-specific antibody (DSA) titers in the recipients that went on to reject their graft was significantly higher compared to those that accepted their grafts. Furthermore, DSA titers increased post-transplantation in the recipients that went on to reject their allografts, whereas DSA titers decreased in those that accepted their grafts. In conclusion, these observations illustrate the efficacy of CTLA-4Ig treatment at controlling rejection in sensitized recipients, and underscore the barrier pre-transplantation DSA poses to long-term graft acceptance. This experimental model also provides a unique opportunity for testing if DSA promotes antibody-mediated rejection or alloreactive memory T cell priming and T cell-mediated rejection in CTLA4-Ig treated recipients, and for identifying therapies that promote long-term graft survival in sensitized recipients.
Donor IL-6 Deficiency Evidently Reduces Memory T Cell Responses in Sensitized Transplant Recipients.

Juntao Chen,Chen Liu,Baoqing Liu,Deqiang Kong,Liang Wen,Weihua Gong

DOI: https://doi.org/10.1016/j.trim.2018.09.005

IF: 2.032

2018-01-01

Transplant Immunology

Abstract:Background: Resistance of tolerance induction in sensitized transplantation is mainly caused by generation of memory T cells. It is unknown whether alteration of graft niche such as level of pro-inflammatory cytokines can affect generation of memory T cells. Methods: IL6 deficient or wildtype (WT) C57BL/6 heart grafts were transplanted into pre-sensitized wildtype BALE/c recipients. Frequencies of memory T cells in the peripheral blood, grafts, and spleen were evaluated. Results: We revealed that deficiency of donor IL6 could significant prolong sensitized allograft survival. Compared with counterpart of WT group, frequency of effector memory CD4 + T cells (CD4 + CD44 + CD62L-) in the peripheral blood was significantly lower in the IL6 KO group (p = .026) at day 3 post-transplantation. Frequency of effector memory CD8 + T cells (CD8 + CD44 + CD62L-) in the peripheral blood was significantly lower in the IL6 KO group (p < .0001) at day 3 post-transplant in comparison to that of WT group. No significant difference of central memory T cells was found between these groups. Histology demonstrated that deficiency of donor pro-inflammatory cytokine IL6 (IL6 KO group) preserved cardiac architecture with a mild infiltration of lymphocytes, whereas wildtype donor (control group) caused an evident lymphocytic infiltration within myocardial fibers of grafts and destruction of cardiac structure. Conclusion: Deficiency of proinflammatory IL6 of donor graft could effectively prolong sensitized allograft survival, which was caused by a remarkable decrease of peripheral memory T cells rather than central memory T cells. This unveiled mechanism of targeting IL6 signaling pathway might provide a novel insight into preventing allograft rejection for sensitized transplant recipients.
Alteration Of Innate Immunity By Donor Il-6 Deficiency In A Presensitized Heart Transplant Model

Fangmin Ge,Shunzong Yuan,Lida Su,Zhonghua Shen,Aibin He,Tao Huang,Weihua Gong

DOI: https://doi.org/10.1371/journal.pone.0077559

IF: 3.7

2013-01-01

PLoS ONE

Abstract:Engraftment of IL-6 deficient donor into wild-type recipient could significantly improve allograft survival through T cell lineage particularly regulatory T cells (Tregs) in non-sensitized transplant host. However, its effect on innate immune responses remains uncertain. Our data revealed that donor IL-6 deficiency significantly increased infiltration of two subsets of MDSCs (CD11b+Gr1+myeloid-derived suppressor cells), CD11b+Gr1(-low) and CD11b+Gr1(-int) with strong immunosuppression activity in the transplanted graft. It resulted in a dramatic increase of CD11b+Gr1(-low) frequency and a significant decrease of the frequency of CD11b+Gr1(-high) and CD4-CD8-NK1.1+ cells in the recipient's spleen. Unexpectedly, donor IL-6 deficiency could not significantly reduce macrophage frequency irrespective of in the host's spleen or graft. Taken together, suppression of innate immune effector cells and enhanced activity of regulatory MDSCs contributed to tolerance induction by blockade of IL-6 signaling pathway. The unveiled novel mechanism of targeting IL-6 might shed light on clinical therapeutic application in preventing accelerated allograft rejection for those pre-sensitized transplant recipients.
Presensitized Immune Condition of Host Exaggerates Prolonged Cold Ischemia-Mediated Injury of Cardiac Graft Involving Regulatory T Cells.

Weihua Gong,Tao Huang,Fangmin Ge,Gaojiang Luo,Shunzong Yuan,Daming Gao,Dong Kong

DOI: https://doi.org/10.1097/tp.0b013e31829df26d

2013-01-01

Transplantation

Abstract:BACKGROUND:The detrimental effect of prolonged cold ischemia time (PCI) on presensitized transplanted graft is conceivable, but the impact of presensitization status of recipient on PCI-mediated graft injury and inflammation is not well defined.METHODS:Allogeneic skin grafts from BALB/c donors were transplanted into C57BL/6 recipients for presensitization. Syngeneic or allogeneic heterotopic heart transplantations with PCI were performed using C57BL/6 or BALB/c donors for these recipients through different treatments.RESULTS:We revealed that PCI could not affect isograft survival but significantly shortened allograft survival in the presensitized recipients. Depletion of regulatory T cells (Tregs) starting 1 day before and after heart transplantation with anti-CD25 monoclonal antibody remarkably induced intragraft Foxp3 gene expression, worsened architecture damage and subepicardial and intramuscle inflammatory cellular infiltration, and caused a dramatic fall of intragraft CD4+/CD8+ ratio, whereas adoptive transfer of exogenous wild-type Tregs or endogenous Tregs promoted by rapamycin had a beneficial effect on preventing the infiltration of T lymphocytes and Gr-1+ neutrophils and reversed intragraft CD4+/CD8+ ratio, preserving cardiac graft architecture. However, their distinct protective mechanisms showed that rapamycin treatment mainly diminished CD4+ T-cell infiltration. Nevertheless, CD4+ still outnumbered CD8+ T cells in the graft, whereas adoptive transfer of Tregs expanded both CD4+ and CD8+ T cells, particularly CD8+ T cells.CONCLUSION:Allogeneic immunoresponses synergistically enhanced PCI effect under presensitized condition. PCI could affect subsequent immunoresponses. Tregs were closely involved in this pathophysiologic process. Our data may pave the way to use Tregs as a novel therapeutic approach to prevent PCI-mediated injury in the presensitized transplant recipients.
An Immunotherapeutic Strategy for Prolonging Graft Survival in Mice.

Feng Wang,Jun Li,Dong Wang,Qian Fu,Yun-yi Xiong,Hui-ting Huang,Long-shan Liu,Chang-xi Wang

DOI: https://doi.org/10.1016/j.trim.2015.08.005

IF: 2.032

2015-01-01

Transplant Immunology

Abstract:Background: Immunological memory is one barrier to inducing immune tolerance in alloantigen primed transplant models. Alloreactive memory cells induced by primary organ transplant are difficult to suppress and contribute to rejection following a retransplant Here, we assess the effects of a novel immunosuppressive strategy on graft survival and host immune response.Materials and methods: Alloantigen primed splenocytes were adoptively transferred into naive B6 mice before heart transplant. Recipient mice were then treated with mitomycin C -pretreated donor-specific transfusion, low dose rapamycin, and anti-OX4OL mAb (alone and in combination).Results: Treatment with donor-specific transfusion + rapamycin + anti-OX4OL increased the mean graft survival time from 52 days (control group) to 42.5 days (p <0.05). None of the grafts in the control group survived past 10 days, and only 1 in 3 grafts survived at least 50 days in the combined treatment group. Compared with the control and single treatment groups, the combination of donor-specific transfusion + rapamycin + antiOX4OL inhibited infiltration of inflammatory cells; reduced the percentages of CD4+ and CD8+ memory T cells in the blood, spleen, and lymph nodes; suppressed inflammatory cytokines; reduced serum IgG levels; and enhanced the percentage of CD4 Foxp3+ T cells. The percentage of regulatory T cells was the highest in the recipients with long-term graft survivalConclusions: The combination of donor-specific transfusion + rapamycin + anti-OX4OL inhibits graft rejection mediated by memory cells and is likely to contribute to prolonged allograft survival (C) 2015 Elsevier B.V. All rights reserved.
Cardiac Allograft Tolerance Induced by Isogeneic CD4+CD25+ Regulatory T Cells.

Xiaoqian Lu,Xian Yang,Qin Zhou,Yuchen Wang,Shi Feng,Juan Jin,Xiujing Shen,Chuan Lin,Hong Jiang,Jianghua Chen

DOI: https://doi.org/10.6002/ect.2013.0148

2014-01-01

Abstract:Objectives: To evaluate the effect of isogeneic CD4+CD25+ regulatory T cells on cardiac allograft tolerance in heterotopic heart transplant from Balb/c to C57BL/6 mice.Materials and Methods: Isogeneic and allogeneic CD4+CD25+ regulatory T cells were obtained from pregnant C57BL/6 mice crossed with male Balb/c mice and from regular Balb/c mice. Recipient C57BL/6 mice were treated with sublethal radiation (2 Gy) and an infusion of isogeneic CD4+CD25+ regulatory T cells, allogeneic CD4+CD25+ regulatory T cells, or phosphate-buffered saline alone 1 day before a Balb/c-to-C57BL/6 heterotopic heart transplant. At 10 days after the transplant, cardiac allografts and the sera of recipients were evaluated with histology and cytokine analysis. Splenocytes of recipients were collected to determine chimerism on the day of the cessation of allograft heartbeat.Results: Mice that received an infusion of isogeneic CD4+CD25+ regulatory T cells had significantly greater mean median survival time, greater degree of chimerism, decreased levels of cytokines (monokine induced by interferon gamma, interleukin 6, interleukin 10, and regulated upon activation, normal T cell expressed and secreted protein), and decreased lymphocytic infiltration than did mice that received phosphate-buffered saline alone. The effects on allograft tolerance were stronger in mice that received the isogeneic than the allogeneic CD4+CD25+ regulatory T cells.Conclusions: Isogeneic CD4+CD25+ regulatory T cells may establish cardiac allograft tolerance by inducing mixed chimerism and suppressing immune responses. Infusion with isogeneic CD4+CD25+ regulatory T cells combined with radiation (sublethal dose, 2 Gy) may establish allograft tolerance in mice. Therefore, further study is warranted because isogeneic CD4+CD25+ regulatory T cells may have therapeutic benefits.
Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Chao Li,Li-Min Zhang,Xue Zhang,Xia Huang,Yong Liu,Ming-Qiang Li,Shuai Xing,Tao Yang,Lin Xie,Feng-Chao Jiang,Han-Ying Jiang,Wen-Tao He,Ping Zhou

DOI: https://doi.org/10.1097/tp.0000000000001471

2016-01-01

Transplantation

Abstract:Background. Most strategies for antirejection and tolerance induction in clinical transplantation have focused on modifying adaptive immunity, it is unclear whether pharmacological suppressing the innate immune systemcan promote transplant tolerance. Methods. We inhibited innate immunity by using our self-generated inhibitor of myeloid differentiation factor 88 (MyD88), TJ-M2010-5, and investigated its therapeutic effects and mechanisms in cardiac and skin transplant models. Results. TJ-M2010-5 directly and indirectly interacted with the Toll/IL-1R domain of MyD88, inhibiting MyD88 homodimerization. In vitro, TJ-M2010-5 inhibited maturation of dendritic cells, which suppressed nuclear translocation of NF-kappa B and Tcell activation. In vivo, short-term (10 days) monotherapy of TJ-M2010-5 resulted in long time survival of 50% of the cardiac allografts, and longer-term (14 days) combination treatment of TJ-M2010-5 with CD154 mAb resulted in survival of 29% of skin allografts, which outperformed far more than CsA did and stimulated the proliferation of CD4(+)CD25(+)FoxP3(+) Regulatory T cells in recipient mice. Conclusions. Pharmacological inhibition of MyD88 signaling by this novel inhibitor TJ-M2010-5 shows a powerful antirejection effect, which may have therapeutic potential in clinical transplantation. The inhibition of both innate and adaptive immunity may be necessary for tolerance induction in nonsolid organs.
Donor Specific Tolerance for MHC Mis-Matched Murine Skin Allograft Induced by Donor Bone Marrow Transplantation with Precondition of High Dose Immunosuppressants

马朝来,张同琳,雷玉涛,罗刚,王坤,孙和新

DOI: https://doi.org/10.3760/cma.j.issn.0254-1785.2004.06.014

2004-01-01

Abstract:Objective To establish a non-irradiated precondition strategy for successful donor specific transplantation tolerance induced by bone marrow transplantation which may be introduced to clinical application by a murine model.Methods Male C57BL/6 and female BALB/c mice were used as skin transplant donors and recipients respectively. In all, 11 groups were studied: group 1, control mice with skin graft and without any other treatment; group 2, mice receiving only donor bone marrow transplantation (DBMT) before skin transplantation; groups 3～5, mice administrated by only high dose FK506, CsA or CTX respectively and then skin transplantation; groups 6～8, mice receiving DBMT preconditioned by high dose FK506, CsA or CTX respectively and followed by skin transplantation. Both skin and bone marrow donors were male C57BL/6 mice in above 8 groups. Mice in groups 9～11 were treated almost equally to groups 6～8 except that skin grafts were from the third party ICR donors to prove specificity of tolerance. Every group included 6 recipients. Survival time of skin graft was recorded. Macrochimerism were examined by PCR method.Results Neither standard dose DBMT nor high dose immnodepressants alone could prolong skin graft survival, and macrochimerism was not detected, either. But skin graft survival time was significantly prolonged and macrochimerism was also detected in mice of 6～8 groups. Survival time of skin graft from the third party mice was not prolonged. Conclusions Bone marrow transplantation preconditioned with high dose immunosuppressants and without irradiation can induce donor specific transplantation tolerance and prolong murine skin graft survival. It may work through the mechanism of establishment of macrochimerism.
Enhanced allogeneic skin-graft survival using sCD95L, sCD152, interleukin-10 and transforming growth factor-β in combination, and comparison with ciclosporin

H. Zheng,G. Du,R. Zhao,B. Tang,N. Zhu

DOI: https://doi.org/10.1111/j.1365-2230.2009.03237.x

2009-01-01

Clinical and Experimental Dermatology

Abstract:P>Background. CD152 is a negative regulator of T-cell activation. The ligand of CD95, CD95L, induces apoptosis in CD95-expressing cells through activation of caspases. Interleukin (IL)-10 and transforming growth factor (TGF)-beta have been implicated in suppressing immune response. Independent treatment with the four factors can induce immunotolerance and prolong the survival of grafts. Aim. To investigate whether joint use of murine (m)IL-10, human (h)TGF-beta and our engineered soluble extracellular part of CD152 and CD95L (sCD152, sCD95L) has a synergistic effect on immunotolerance induction in allogeneic skin transplantation. Methods. Recipient mice were treated with sCD152, sCD95L, mIL-10 and hTGF-beta, separately or combined. The survival time of skin allografts was observed and mixed lymphocyte reactions were performed to detect the reactivity of splenic cells from recipient mice compared with splenic cells from donors or from unrelated Institute of Cancer Research mice. The levels of cytokines such as IL-2, IL-4 and interferon (IFN)-gamma, and antibodies specific for engineered sCD152 or sCD95L in serum were determined by ELISA. Results. Combined treatment with sCD152 and sCD95L synergistically prolonged the mean survival time (MST) of skin allografts, but the addition of mIL-10 or hTGF-beta to these did not improve MST further. Conclusion. sCD152 and/or sCD95L regulate the differentiation of T-helper (Th) cells and induce the cytokine production shift of Th1-associated and Th2-associated cells. Both IFN-gamma and IL-2 were negatively correlated and IL-4 was positively correlated with skin MST. Cytokines such as IFN-gamma, IL-2 and IL-4 might function as indicators for predicting graft survival time.
Depletion of donor dendritic cells ameliorates immunogenicity of both skin and hind limb transplants

Muhammad Imtiaz Ashraf,Joerg Mengwasser,Anja Reutzel-Selke,Dietrich Polenz,Kirsten Führer,Steffen Lippert,Peter Tang,Edward Michaelis,Rusan Catar,Johann Pratschke,Christian Witzel,Igor M. Sauer,Stefan G. Tullius,Barbara Kern

DOI: https://doi.org/10.3389/fimmu.2024.1395945

IF: 7.3

2024-05-11

Frontiers in Immunology

Abstract:Acute cellular rejection remains a significant obstacle affecting successful outcomes of organ transplantation including vascularized composite tissue allografts (VCA). Donor antigen presenting cells (APCs), particularly dendritic cells (DCs), orchestrate early alloimmune responses by activating recipient effector T cells. Employing a targeted approach, we investigated the impact of donor-derived conventional DCs (cDCs) and APCs on the immunogenicity of skin and skin-containing VCA grafts, using mouse models of skin and hind limb transplantation. By post-transplantation day 6, skin grafts demonstrated severe rejections, characterized by predominance of recipient CD4 T cells. In contrast, hind limb grafts showed moderate rejection, primarily infiltrated by CD8 T cells. Notably, the skin component exhibited heightened immunogenicity when compared to the entire VCA, evidenced by increased frequencies of pan (CD11b - CD11c + ), mature (CD11b - CD11c + MHCII + ) and active (CD11b - CD11c + CD40 + ) DCs and cDC2 subset (CD11b + CD11c + MHCII + ) in the lymphoid tissues and the blood of skin transplant recipients. While donor depletion of cDC and APC reduced frequencies, maturation and activation of DCs in all analyzed tissues of skin transplant recipients, reduction in DC activities was only observed in the spleen of hind limb recipients. Donor cDC and APC depletion did not impact all lymphocyte compartments but significantly affected CD8 T cells and activated CD4 T in lymph nodes of skin recipients. Moreover, both donor APC and cDC depletion attenuated the Th17 immune response, evident by significantly reduced Th17 (CD4 + IL-17 + ) cells in the spleen of skin recipients and reduced levels of IL-17E and lymphotoxin-α in the serum samples of both skin and hind limb recipients. In conclusion, our findings underscore the highly immunogenic nature of skin component in VCA. The depletion of donor APCs and cDCs mitigates the immunogenicity of skin grafts while exerting minimal impact on VCA.

immunology
ADDITIVE EFFECTS OF ANTI-CD3 AND ANTI-CD28 ON PROLONGATION OF ALLOGENEIC SKINGRAFT SURVIVAL

Xue-Zhong Yu,Yoshio Nitta,Sasha J. Bidwell,Claudio Anasetti

DOI: https://doi.org/10.1097/00007890-200112150-00030

2001-01-01

Transplantation

Abstract:T cells play a critical role in allograft rejection. T-cell activation requires antigen recognition by the T-cell receptor (TCR)/CD3 complex and costimulation of accessory receptors. Non-FcR-binding anti-CD3ε antibodies (Abs) produce immunosuppression without the toxicity associated with Fc-dependent activation (1). Non-FcR-binding anti-CD3ε Abs may induce T-cell anergy, skew the T-cell repertoire toward the Th2 phenotype, modulate the TCR, and block antigen recognition (1). We have found that a critical mechanism of immunosuppression by non-FcR-binding anti-CD3ε Abs is the induction of apoptosis in antigen-activated T cells (2). Among the costimulatory receptors on T cells, CD28 has a pivotal role in the initiation and maintenance of T-cell responses. In various transplant models, inhibition of CD28:B7 interactions by CTLA4-Ig resulted in immunosuppression (3). However, treatment with anti-CD28 Abs was more effective than CTLA4-Ig in the prevention of graft-versus-host disease in mice (4). Therefore, selective targeting of CD28 may be a better approach to achieve transplantation tolerance than blocking B7 molecules, the ligands for both CD28 and CTLA4, as CTLA4 is inhibitory for T-cell activation. Here we tested the hypothesis that combined treatment with non-FcR-binding anti-CD3ε plus anti-CD28 Abs leads to transplantation tolerance by affecting independent and complementary pathways of T cell activation. The experiments were performed in the context of a strong allogeneic MHC stimulation by transplanting skin grafts from BALB/c (H2d) onto C57BL/6 (H2b) mice. Recipients were treated with control Ab, anti-CD28 alone, non-FcR-binding anti-CD3ε alone, or anti-CD3ε plus anti-CD28. As shown in Figure 1A, treatment with anti-CD3 significantly prolonged graft survival compared to control or anti-CD28 treatment (P <0.0001, P <0.0001), whereas anti-CD28 by itself was modestly effective (P =0.002). The combination of anti-CD3ε plus anti-CD28 Abs was significantly more effective than either Ab alone (P =0.002, and P <0.0001), but transplantation tolerance did not develop. We suspected that failure to achieve graft tolerance could result from non-tolerant T cells developing from the thymus after stopping treatment. These T cells could recognize alloantigens and reject the skin graft. To test this hypothesis, we utilized thymectomized C57BL/6 mice as recipients. Treatment with anti-CD3ε plus anti-CD28 Abs significantly prolonged graft survival compared to control Ab (Fig. 1B), but the magnitude of the effect was not significantly different in normal or thymectomized recipients (P =0.5). Figure 1: Prolongation of murine skin allograft survival. Normal (A) or thymectomized (B) C57BL/6 mice were transplanted with full-thickness skin grafts from BALB/c donors. Recipients were intraperitoneally injected with the reagents indicated once every other day for a total of eight doses. The dose of anti-CD3ε and anti-CD28 Abs were 80 and 100 μg/mouse, respectively. The control Ab used was normal hamster IgG.We conclude that anti-CD3 and anti-CD28 Abs have additive immunosuppressive effects, but their combination does not induce tolerance to skin transplants. The failure of inducing transplantation tolerance with this treatment is not caused by the emergence of non-tolerant T cells from the host thymus, but may result from incomplete depletion of alloreactive T cells, lack of inducing T-cell unresponsiveness, and/or lack of generating regulatory T cells. Xue-Zhong Yu1 Yoshio Nitta2,3 Sasha J. Bidwell1 Claudio Anasetti1,4
Donor-Specific Regulatory T Cells Acquired from Tolerant Mice Bearing Cardiac Allograft Promote Mixed Chimerism and Prolong Intestinal Allograft Survival

Xiao-Fei Shen,Jin-Peng Jiang,Jian-Jun Yang,Wei-Zhong Wang,Wen-Xian Guan,Jun-Feng Du

DOI: https://doi.org/10.3389/fimmu.2016.00511

IF: 7.3

2016-01-01

Frontiers in Immunology

Abstract:The induction of donor-specific transplant tolerance has always been a central problem for small bowel transplantation (SBT), which is thought to be the best therapy for end-stage bowel failure. With the development of new tolerance-inducing strategies, mixed chimerism induced by co-stimulation blockade has become most potent for tolerance of allografts, such as skin, kidney, and heart. However, a lack of clinically available co-stimulation blockers has hindered efficient application in humans. Furthermore, unlike those for other types of solid organ transplantation, strategies to induce robust mixed chimerism for intestinal allografts have not been fully developed. To improve current mixed chimerism induction protocols for future clinical application, we developed a new protocol using donor-specific regulatory T (Treg) cells from mice with heart allograft tolerance, immunosuppressive drugs which could be used clinically and low doses of irradiation. Our results demonstrated that donor-specific Treg cells acquired from tolerant mice after in vitro expansion generate stable chimerism and lead to acceptance of intestinal allograft. Increased intragraft Treg cells and clonal deletion contribute to the development of SBT tolerance.
Inactivation Of T-Cell Receptor-Mediated Integrin Activation Prolongs Allograft Survival In Amap-Deficient Mice

Jiong Tian,Oliver Pabst,Dorothee Roemermann,Susanne Skubich,Reinhold Foerster,Jan Beckmann,Jiang-Hua Chen,Matthias W. Hoffmann

DOI: https://doi.org/10.1097/01.tp.0000269724.06142.92

2007-01-01

Transplantation

Abstract:Background. Signaling through the T cell receptor (TCR) leads to profound changes in the function and properties of T cells, including integrin activation. Adhesion and degranulation promoting adapter protein (ADAP) is an adapter protein linking T cell receptor stimulation to integrin activation. We aim to clarify how disruption of TCR-mediated integrin activation affects alloreactive immune responses.Methods. In vitro T cell proliferation and the cytokine production was determined. In vivo cytotoxic T lymphocyte (CTL) activity was measured as well. Allogenic skin and heart transplantation was used to test the in vivo role of ADAP in alloimmune responses. Histology and flow cytometry was applied to analyze the graft infiltrating lymphocytes.Results. Upon stimulation with allogenic dendritic cells ADAP-deficient T cells displayed impaired proliferative responses compared to wild type (WT) T cells. This was accompanied by significantly decreased production of the cytokine interleukin-2. In contrast, the in vivo CTL activity in ADAP-deficient mice was comparable to that of WT mice. Consistently, we observed a prolongation of fully major histocompatibility complex (MHC)-mismatched heart transplants in ADAP deficient mice. Protection of allogenic heart grafts in ADAP-deficient mice was accompanied by a decrease in the infiltration, proliferation and activation of T cells in the allograft. However, no effect was observed after fully MHC-mismatched skin transplantation.Conclusions. We have shown that although ADAP is dispensable for the rejection of allografts, ADAP function plays an important role for the efficacy of graft rejection. ADAP's main function appears to affect the induction phase of the immune response.
Anti-ICAM-1 Antibody and CTLA-4Ig Synergistically Enhance Immature Dendritic Cells to Induce Donor-Specific Immune Tolerance in Vivo

QX Wang,M Zhang,GS Ding,YS Liu,YP Sun,JL Wang,WP Zhang,ZR Fu,XT Cao

DOI: https://doi.org/10.1016/s0165-2478(03)00160-3

IF: 4.23

2003-01-01

Immunology Letters

Abstract:Immature dendritic cells (DC) have been demonstrated to induce T-cell hyporesponsiveness in vitro and immune tolerance in vivo. However, immature DC (iDC) may become mature once infused in vivo, thus limiting the prolongation of the allograft survival. Considering that mature DC express high level of B7, intercellular adhesion molecule-1 (ICAM-1), and T-cell activation needs costimulation signals provided by DC, we selected anti-ICAM-1 mAb and cytotoxic T lymphocyte antigen-4Ig fusion protein (CTLA-4Ig) for in vivo administration to block costimulation pathways in order to further improve the efficacy of iDC to induce immune tolerance. Seven days before allogeneic cardiac transplantations, the recipients were intravenously (i.v.) pretreated of donor-derived iDC with or without simultaneous injections of anti-ICAM-1 mAb and CTLA-4Ig. CTLA-4Ig or anti-ICAM-1 mAb administration alone resulted in significant prolongation of cardiac allograft survival induced by iDC. When used simultaneously, CTLA-4Ig and anti-ICAM-1 mAb induced permanent allografts acceptance even in 90% recipients. The recipients could keep the skin alive for a longer time in the donor-specific second transplantation, but no effect was observed on the skin from C3H third-party mice. The efficient induction of donor-specific tolerance observed above may be related to the more potent inhibition of donor-specific T-cell responses including cytotoxicity activity, Th1 cytokines production, and alloantibody production by the combined use of anti-ICAM-1 mAb and CTLA-4Ig. Our data suggest that anti-ICAM-1 antibody and CTLA-4Ig can synergistically enhance iDC to induce donor-specific immune tolerance in vivo.
In Vivo Environment Necessary to Support Transplanted Donor Mouse T Regulatory Cells

C. Cabello-Kindelan,A. de la Barrera,T. R. Malek,A. L. Bayer

DOI: https://doi.org/10.1111/ajt.12650

IF: 9.369

2014-03-11

American Journal of Transplantation

Abstract:CD4(+) Foxp3(+) T regulatory cells (Tregs ) are essential for maintaining immunological tolerance, which could be harnessed for novel cell-based therapies to prevent allograft rejection and control autoimmunity. However, the use of Tregs for therapy is hindered by the inability to generate sufficient cell numbers to inhibit desired immune response(s) and achieve stable engraftment of the donor-Treg cell inoculums. The present study was undertaken to investigate the in vivo requirements to promote engraftment of adoptively transferred Tregs and induce tolerance. We established that not only is peripheral space required, but competition from endogenous Tregs must be minimized for successful donor-Treg engraftment with IL-2 critical for driving their proliferation and survival. Moreover, these studies revealed a critical level of donor-Treg engraftment was required for tolerance induction to skin transplants. These mouse studies lay the foundation for development of novel Treg approaches for tolerance induction in the clinic involving not only organ or cellular transplantation, but also to re-establish self-tolerance in autoimmune settings.

surgery,transplantation
Mechanism of Donor Antigen-Specific CD4+CD25+regulatory T Cells on Prolonging Islet Grafts Survival

张梅,徐书杭,徐瑜,刘翠萍,茅晓东,徐宽枫,刘超

DOI: https://doi.org/10.3969/j.issn.1005-6947.2008.09.010

2008-01-01

Abstract:Objective To investigate the potential mechanism of antigen-specific CD4+CD25+ regulatory T cells on the suppression of rejection for allogenetic islet transplantation in vivo.Methods Islets with 8×105 antigen-specific Treg were allogeneically transplanted under the kidney capsule of streptozotocin-induced diabetic BALB/cByJ mice.Mean survival time(MST),the ratio of CD4+/CD8+ T cells,cytokine expression in both tolerant and rejected mice was detected.Results In vivo,the mean survival time of recipients with islets and antigen-specific CD4+CD25+ Treg group(C group) was(34.57±17.15) days,whereas transplanted islets without Treg treatment(B group) survived a mean time of(10.60±1.82)d(P0.01).The ratio of CD4+/CD8+ T cells from antigen-specific CD4+CD25+ Treg transplantation group was significantly lower than that from islet transplantation group(P0.01).The mRNA expressions of IL-10,TGF-β were upregulated in antigen-specific CD4+CD25+ Treg transplantation group.However,themRNA expressions of IL-1β,IL-2,IFN-γ were similarly upregulated in islet B group.Conclusions Allogeneic antigen-specific CD4+CD25+ Treg cells can prolong islet graft survival by the mechanism of affecting Th2/Th1 cells responses.
Amplification of Memory T Cells in Mice by Rejection after Skin Transplantation

CHENG Gong,CHEN Ming,SUN Ze-yu,ZHANG Gu-tian

DOI: https://doi.org/10.3969/j.issn.1671-7856.2008.04.008

2008-01-01

Abstract:Objective To describe a stab increased state of memory T cells in mice induced by rejection after skin transplantation. Methods The skin of DBA/2 mice was used as donor and transplanted into C57BL/6 mice as host. At the same time, skin of C57BL/6 donor mice was transplanted into C57BL/6 host mice as control. The ratio of memory T cells in spleeen mononuclear cells (SPM) from hosts was determined by flow cytometry each week (n=10) during 8 weeks after operation. Results (1) Heterologous series:here was a significant increase in the ratio of memory T cells from SPM at 4th week after operation, compared with that at 1～3 weeks (P<0.01), as well as at 5～8 weeks compared with that at 4th week after operation (P<0.01). There was no significant increase in the ratio of memory T cells during the period of 1～3 (P>0.05) weeks after operation as well as during the period of 5～8 weeks (P>0.05). (2) Homologous series: There was no significant increase in the ratio of memory T cells during 1～8 weeks after operation (P>0.05). Conclusion The memory T cells show a stably increased proliferation since 4～5 weeks after the exposure to skin allogenic antigen in mice. This mouse model with a stably increased ratio of memory T cells can be useful in transplantation studies.
The Australian 75+ Health Assessment: could it detect early functional decline better?

K. Grimmer,K. Kennedy,S. Milanese,K. Price,D. Kay

DOI: https://doi.org/10.1071/AH15011

2016-02-22

Australian Health Review

Abstract:OBJECTIVE The aim of the present study was to identify opportunities to improve the reach and impact of the Australian Medicare 75+ Health Assessment (75+HA) to detect early functional decline (FD). METHODS A comparison of two published review articles produced two outputs: (1) assessments identified in the systematic review that underpinned the 75+HA items were ranked for evidence of effectiveness and compared with the volume of research into assessment areas identified by a recent review on indicators of early FD; and (2) items in the 75+HA were compared with those in the recent review. RESULTS The review underpinning the 75+HA found 19 assessment areas, with strongest evidence of effectiveness for vision/hearing, teeth/oral, balance/gait, cognitive and service use. The more recent review reported on six domains (eight subdomains) of FD assessment: physical and cognitive elements of the performance capacity domain were the least well assessed, whereas the most comprehensively assessed domains were health service use, performance capacity (mental subdomain), participation (motivation/volition subdomain) and demographics. The 75+HA addresses only some items related to early FD as identified by the recent literature. CONCLUSION Reassessment of the 75+HA with a view to including current evidence-based assessments for early FD is recommended. Updating the 75+HA items with ways to detect FD earlier may increase its relevance to Australia's ageing population.
Induction of Immunotolerance in Mice after Skin Allotransplantation by Subcutaneous Injection of Bone Marrow

戎瑞明,张永康,朱同玉,王杭

DOI: https://doi.org/10.3969/j.issn.1672-8467.2002.03.011

2002-01-01

Abstract:Purpose To study the possibility of using subcutaneous injection of donor specific bone marrow(BM) and intaking a short time cyclosporine A(CyA) to induce murine immunotolerance after skin allotransplantation. Methods We made tail to tail skin transplantation between BABL/c(donor) and C57BL/6(recipient)that were all 8 weeks old.The recipients were divided into 5 groups,group A had a long term intake of CyA and group B to E were injected with different dose of donor specific BM subcutaneously and in different time,they were only treated by abdominal injection of CyA for a short time(7-11 days).The synthetical scores and survival time of skin allografts in these mice were recorded. Results The mice in group B and C were injected with BM 1×10 5 or 1×10 6 qod in the day 0-11,when the injection of CyA stop,their skin grafts were rejected soon,the average survival time was 27 days;injection of BM 1×10 7 in day 0,4,8,11 or BM 1×10 8 in day 0,5,10 into the mice in group D and E,prolonged their skin allograft survival to averge 48 or 55 days,which were so long as those in the group A(54 days). Conclusions Subcutaneous injection of donor specific BM combined with a shortterm intaking of CyA can induce a temporary tolerance to the allograft and also prolong the averge survival time of it;this successful induction is related with the dose of BM and the injective patten,large dose with long interval injection gets more successful induction.
Oral Alloantigen Exposure Promotes Donor‐specific Tolerance in a Mouse Model of Minor‐Mismatched Skin Transplantation

Peter Wang,Luqiu Chen,Christine M. McIntosh,Jorden I. Lane,Rena Li,Stephen Z. Xie,Husain Sattar,Daria Esterhazy,Anita S. Chong,Maria‐Luisa Alegre

DOI: https://doi.org/10.1111/ajt.17107

IF: 9.369

2022-05-30

American Journal of Transplantation

Abstract:Oral antigen exposure is a powerful, non‐invasive route to induce immune tolerance to dietary antigens, and has been modestly successful at prolonging graft survival in rodent models of transplantation. To harness the mechanisms of oral tolerance for promoting long‐term graft acceptance, we developed a mouse model where the antigen ovalbumin (OVA) was introduced orally prior to transplantation with skin grafts expressing OVA. Oral OVA treatment pre‐transplantation promoted permanent graft acceptance and linked tolerance to skin grafts expressing OVA fused to the additional antigen 2W. Tolerance was donor‐specific, as secondary donor‐matched, but not third party allografts were spontaneously accepted. Oral OVA treatment promoted an anergic phenotype in OVA‐reactive CD4+ and CD8+ conventional T cells (Tconvs) and expanded OVA‐reactive Tregs pre‐transplantation. However, skin graft acceptance following oral OVA resisted partial depletion of Tregs and blockade of PD‐L1. Mechanistically, we revealed a role for the proximal gut draining lymph nodes (gdLNs) in mediating this effect, as an intestinal infection that drains to the proximal gdLNs prevented tolerance induction. Our study extends previous work applying oral antigen exposure to transplantation and serves as proof of concept that the systemic immune mechanisms supporting oral tolerance are sufficient to promote long‐term graft acceptance.

surgery,transplantation

Covert manifestations of child abuse.

Efficacy of Ctla4-Ig in Preventing Acute Rejection of Fully Allogeneic Heart Allografts in Sensitized Recipients

Donor IL-6 Deficiency Evidently Reduces Memory T Cell Responses in Sensitized Transplant Recipients.

Alteration Of Innate Immunity By Donor Il-6 Deficiency In A Presensitized Heart Transplant Model

Presensitized Immune Condition of Host Exaggerates Prolonged Cold Ischemia-Mediated Injury of Cardiac Graft Involving Regulatory T Cells.

An Immunotherapeutic Strategy for Prolonging Graft Survival in Mice.

Cardiac Allograft Tolerance Induced by Isogeneic CD4+CD25+ Regulatory T Cells.

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Donor Specific Tolerance for MHC Mis-Matched Murine Skin Allograft Induced by Donor Bone Marrow Transplantation with Precondition of High Dose Immunosuppressants

Enhanced allogeneic skin-graft survival using sCD95L, sCD152, interleukin-10 and transforming growth factor-β in combination, and comparison with ciclosporin

Depletion of donor dendritic cells ameliorates immunogenicity of both skin and hind limb transplants

ADDITIVE EFFECTS OF ANTI-CD3 AND ANTI-CD28 ON PROLONGATION OF ALLOGENEIC SKINGRAFT SURVIVAL

Donor-Specific Regulatory T Cells Acquired from Tolerant Mice Bearing Cardiac Allograft Promote Mixed Chimerism and Prolong Intestinal Allograft Survival

Inactivation Of T-Cell Receptor-Mediated Integrin Activation Prolongs Allograft Survival In Amap-Deficient Mice

Anti-ICAM-1 Antibody and CTLA-4Ig Synergistically Enhance Immature Dendritic Cells to Induce Donor-Specific Immune Tolerance in Vivo

In Vivo Environment Necessary to Support Transplanted Donor Mouse T Regulatory Cells

Mechanism of Donor Antigen-Specific CD4+CD25+regulatory T Cells on Prolonging Islet Grafts Survival

Amplification of Memory T Cells in Mice by Rejection after Skin Transplantation

The Australian 75+ Health Assessment: could it detect early functional decline better?

Induction of Immunotolerance in Mice after Skin Allotransplantation by Subcutaneous Injection of Bone Marrow

Oral Alloantigen Exposure Promotes Donor‐specific Tolerance in a Mouse Model of Minor‐Mismatched Skin Transplantation